PROXY

Company

Celldex Therapeutics, Inc.

Filed

April 13, 1998

Period of Report

December 31, 1997

Accession Number

0001029869-98-000494

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →